Osimertinib is prescribed to prevent the recurrence of non-small-cell lung cancer after it is removed surgically. This drug can also be used as the first treatment for certain types of non-small-cell lung cancer that have spread to other parts of the body. It belongs to the drug group called kinase inhibitors.

Recently Answered Questions Recently Answered Questions

All the answers published in this website are written by Verified medical doctors, therapists and health experts. The Content has been moderated by iCliniq medical review team before publication. Post your medical clarifications on iCliniq by choosing the right specialty and get them answered. Your medical queries will be answered 24/7 by top doctors from iCliniq.

How long will it take for Tagrisso to cause resistance?

Query: Hello doctor, My brother os recently on Tagrisso. His recent scan is attached which shows improvement. He is vomiting while eating grains. What is the reason for vomiting and what can be done for this? Please tell me about this response to Tagrisso. If it is good? How much time does Tagrisso take ...  Read Full »

Dr. Vikas T. Talreja

Answer: Hi, Welcome to icliniq.com. In reply to your question for Osimertinib (Tagrisso), Osimertinib demonstrated improvement in PFS (18.9 versus 10.2 months, HR 0.46, 95% CI 0.37-0.57) and duration of response (17.2 versus 8.5 months) relative to other TKI. The PFS (progression-free survival) benefit w...  Read Full »

ask-doctor-img Ask a Doctor Online

* Your first query consult is free!

Search for a Health Issue

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.